Standard BioTools, is engaged in product rationalization, cost-cutting and operational efficiency measures in an attempt to turn its business around and transition to profitability. The company’s ...
Commenting on the ISS recommendation, SomaLogic issued the following statement: SomaLogic is pleased that ISS shares its belief that the merger with Standard BioTools is in the best interests of all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results